Potential for Dependence on Lisdexamfetamine - In vivo and In vitro Aspects |
Yun, Jaesuk
(Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Lee, Kwang-Wook (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Eom, Jang-Hyeon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kim, Young-Hoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Shin, Jisoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Han, Kyoungmoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Park, Hye-Kyung (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kim, Hyung Soo (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Cha, Hye Jin (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) |
1 | Gonatas, N. K., Autilio-Gambetti, L., Gambetti, P. and Shafer, B. (1971) Morphological and biochemical changes in rat synaptosome fractions during neonatal development. J. Cell Biol. 51, 484-498. DOI |
2 | Gorelick, D. A., Gardner, E. L. and Xi, Z. X. (2004) Agents in development for the management of cocaine abuse. Drugs 64, 1547-1573. DOI |
3 | Heal, D. J. and Pierce, D. M. (2006) Methylphenidate and its isomers. CNS Drugs 20, 713-738. DOI |
4 | Heal, D. J.,Cheetham, S. C. and Smith, S. L. (2009) The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57, 608-618. DOI |
5 | Heal, D. J., Buckley, N. W., Gosden, J., Slater, N., France, C. P. and Hackett, D. (2013) A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to D-amfetamine, methylphenidate and modafinil. Neuropharmacology 73, 348-358. DOI |
6 | Hurd, Y. L. and Ungerstedt, U. (1989) dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur. J. Pharmacol. 166, 261-269. DOI |
7 | Ivannikov, M. V., Sugimori, M. and Llinás, R. R. (2013) Synaptic vesicle exocytosis in hippocampal synaptosomes correlates directly with total mitochondrial volume. J. Mol. Neurosci. 49, 223-230. DOI |
8 | Janowsky, A., Neve, K. and Eshleman, A. J. (2001) Uptake and release of neurotransmitters. Curr. Protoc. Neurosci. Chapter 7, Unit7.9. |
9 | Jasinski, D. R. and Krishnan, S. (2009) Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. J. Psychopharmacol. 23, 419-427. DOI |
10 | Kamat, P. K., Kalani, A. and Tyagi, N. (2014) Method and validation of synaptosomal preparation for isolation of synaptic membrane proteins from rat brain. MethodsX 1, 102-107. DOI |
11 | McKenna, D. J., Guan, X. M. and Shulgin, A. T. (1991) 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of -dopamine and -5-hydroxytryptamine. Pharmacol. Biochem. Behav. 38, 505-512. DOI |
12 | Koob, G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmcaol. Sci. 13, 177-184. DOI |
13 | Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea-Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., Kung, H. F. and Innis, R. B. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. J. Nucl. Med. 36, 1182-1190. |
14 | Mantle, T. J., Tipton, K. F. and Garrett, N. J. (1976) Inhibition of monoamine oxidase by amphetamine and related compounds. Biochem. Pharmacol. 25, 2073-2077. DOI |
15 | Narita, M., Akai, H., Nagumo, Y., Sunagawa, N., Hasebe, K., Nagase, H., Kita, T., Hara, C. and Suzuki, T. (2004) Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience 127, 941-948. DOI |
16 | Meyer, J. S. and Quenzer, L. F. (2013) Psychopharmacology: Drugs the Brain, and Behavior (2nd edition), p. 150. Sinauer Associates Inc., Sunderland. |
17 | Mucha, R. F., van der Kooy, D., O'Shaughnessy, M. and Bucenieks P. (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243, 91-105. DOI |
18 | Nagy, A. and Delgado-Escueta, A. V. (1984) Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient material (Percoll). J. Neurochem. 43, 1114-1123. DOI |
19 | National Research Center (2001) Guide for the Care and Use of Laboratory Animals (8th edition). National Academy of Sciences, Washington. |
20 | Koob, G. F. (1996) Drug addiction: the yin and yang of hedonic homeostasis. Neuron 16, 893-896. DOI |
21 | Whittaker, V. P., Michaelson, I. A. and Kirkland, R. J. (1964) The separation of synaptic vesicles from nerve-ending particles ('synaptosomes'). Biochem. J. 90, 293-303. DOI |
22 | Pennick, M. (2010) Absorption of lisdexamfetaminedimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr. Dis. Treat. 6, 317-327. |
23 | Rowley, H. L., Kulkarni, R. S., Gosden, J., Brammer, R. J., Hackett, D. and Heal, D. J. (2014) Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats. J. Psychopharmacol. 28, 254-269. DOI |
24 | Sherman, A. D. (1989) Isolation of metabolically distinct synaptosomes on Percoll gradients. Neurochem. Res. 14, 97-101. DOI |
25 | Taylor, C. Z. (2002) Religious addiction: obsession with spirituality. Pastor. Psychol. 50, 291-315. DOI |
26 | Ward, A. S., Li, D. H., Luedtke, R. R. and Emmett-Oglesby, M. W. (1996) Variations in cocaine self-administration by inbred rat strains under a progressive-ratio schedule. Psychopharmacology (Berl.) 127, 204-212. DOI |
27 | Whittaker, V. P. (1965) The application of subcellular fractionation techniques to the study of brain function. Prog. Biophys. Mol. Biol. 15, 39-96. DOI |
28 | Wislet-Gendebien, S., Visanji, N. P., Whitehead, S. N., Marsilio, D., Hou, W., Figeys, D., Fraser, P. E., Bennett, S. A. and Tandon, A. (2008) Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors. BMC Neurosci. 9, 92. DOI |
29 | Nestler, E. J. (2013) Cellular basis of memory for addiction. Dialogues Clin. Neurosci. 15, 431-443. |
30 | Abekawa, T., Ohmori, T. and Koyama, T. (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643, 276-281. DOI |
31 | Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L. and Mathis, C. A. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry 49, 81-96. DOI |
32 | Bozarth, M. A. (1987) Conditioned place preference: a parametric analysis using systemic heroin injections. In Methods of Assessing the Reinforcing Properties of Abused Drugs (M. A. Bozarth, Ed.), pp 241-273. Springer, New York. |